Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients

ClinicalTrials.gov ID: NCT00960804

Public ClinicalTrials.gov record NCT00960804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 27, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, LONG-TERM SAFETY STUDY OF TANEZUMAB IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP

Study identification

NCT ID
NCT00960804
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
21 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Other
  • Tanezumab Biological

Other · Biological

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2010
Primary completion
Nov 10, 2010
Completion
Nov 10, 2010
Last update posted
Feb 7, 2021

2010

United States locations

U.S. sites
18
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Jem Research, LLC Atlantis Florida 33462
Medical Specialists of the Palm Beaches Atlantis Florida 33462
Clinical Physiology Associates, Clinical Study Center Fort Myers Florida 33916
Harris Bonnette, MD Fort Myers Florida 33919
Arthritis & Rheumatic Care Center South Miami Florida 33143
Miami Research Associates South Miami Florida 33143
Neuroscience Consultants, LLC South Miami Florida 33143
Asheville Imaging Asheville North Carolina 28801
Biltmore Medical Associates Asheville North Carolina 28801
Clinical Study Center of Asheville, LLC Asheville North Carolina 28803
Asheville Neurology Asheville North Carolina 28806-2287
Ohio Research Center Toledo Ohio 43623
Blair Neurologic Associates Altoona Pennsylvania 16601
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Coastal Carolina Research Center in Goose Creek Goose Creek South Carolina 29445
Tidewater Neurology Goose Creek South Carolina 29445
Neurodiagnostic Laboratories of San Antonio, Inc San Antonio Texas 78229
Radiant Research, Inc. San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00960804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2021 · Synced Apr 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00960804 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →